Info for Treatment Providers:
Information regarding buprenorphine treatment, addiction and other related topics for Physicians, Therapists/Counselors and Pharmacists.
Adobe Acrobat Viewer is required to view Adobe Acrobat (PDF) files. If you don't have Acrobat Viewer already installed, click here to download it now.Up-to-date Patient/Physician Matching System Statistics |
Learn about the Patient/Physician Matching System – PPMS Click here to view National Patient Map |
What is the Patient/Physician Matching System?
PPMS physician registration instructions.
Interactive demo of recent improvements to the Physician side of the Matching System.
SAMHSA Physician Locator (add, delete, edit)
Physicians already listed on the locator but want to make a change, add a practice location or delete their listing, can now do that themselves online. Click this link for instructions: http://buprenorphine.samhsa.gov/pls/bwns/updtcntct2$.startup
If not already listed, DATA-2000 waived physicians may call 1-866-BUP-CSAT (1-866-287-2728) or e-mail info@buprenorphine.samhsa.gov with requests to be added to the Locator. See current locator listing at: www.naabt.org/local
The DEA must also be notified when a waived physician changes the primary practice address at which they intend to treat opioid addiction under the authority of their DATA 2000 waiver. Call the DEA Office of Diversion Control at 1-800-882-9539. Phone numbers for local DEA offices can be found on the DEA Web site at http://www.dea.gov.
Substance Abuse and Mental Health Services Administration (SAMHSA) website
Physician Certification.
How to become certified to prescribe buprenorphine for opioid addiction.
Physician Buprenorphine Certification Events – both live and online.
American Society of Addiction Medicine (ASAM) online certification training.
American Academy of Addiction Psychiatry (AAAP) online certification training.
American Psychiatric Association (APA) online certification training.
APA certification training brochure.
Physician Clinical Support System (PCSS).
A National Mentoring Network for Physicians Treating Opioid Dependence.
What is the PCSS?
The SAMHSA-funded PCSS is designed to assist practicing physicians, in accordance with the Drug Addiction Treatment Act of 2000, in incorporating into their practices the treatment of prescription opioid and heroin dependent patients using buprenorphine.
The PCSS service is available, at no cost, to interested physicians and staff, to assist in implementing office-based treatment of opioid dependence with buprenorphine. The essential elements of the PCSS are a national network of trained physician mentors with expertise in buprenorphine treatment and skilled in clinical education, who will be supported by National experts in the use of buprenorphine and a medical director. Click here for more about PCSS.
Phone: 877.630.8812 Brochure email: PCSSproject@asam.org site: PCSSmentor.org
PCSS Clinical Guidelines.
PCSS disclaimer
“Disclaimer for PCSS Clinical Guidances
The PCSS Clinical Guidances have been developed as a resource for interested physicians, but the PCSS program is only a vehicle for the sharing of knowledge and information; it is not a referral mechanism. While it is expected that inquiries presented to mentoring physicians will be based on fact patterns related to actual cases, remarks and opinions from mentoring physicians should be understood as being general in nature and not directed at a specific patient or case. Opinions and counsel from a mentor should not be used as a substitute for the opinion, judgment, and knowledge of the treating physician. No physician-patient or other relationship, expressed or implied, is created between a mentoring physician and any patient by virtue of participation in the PCSS program.”
Physician Billing for office based treatment of opioid dependence 11-5-05
Treatment of Acute Pain in patients receiving buprenorphine/naloxone 11-10-05
Transfer from Methadone to Buprenorphine 8-9-06
Pregnancy and buprenorphine treatment 3-21-06
Buprenorphine/naloxone treatment and Liver function 11-22-05
Opioid Therapies, HIV disease and drug interactions 10-10-06
Patient Online Support Community.
In some areas patients are unable to find a “medication friendly” support group. These patients may benefit from online patient peer support. Patients can participate 24/7 in the online buprenorphine community at: http://www.naabt.org/forum
Most popular physician downloads.
Physician and Pharmacist Frequently Asked Questions.
1-5-2007 NEW Blank "intent" form to treat up to 100 patients--fax to 240-276-1630
TIP 40 PDF (Clinical Guidelines for the Use of Buprenorphine) More TIPs on literature page
The 3 day rule (dispensing buprenorphine without a waiver)
DEA Articulates Policy on the Use of Buprenorphine for Pain- Letter to Dr. Heit
Other DEA regulations cleared up
Treating pain in buprenorphine maintained patients (Ann Intern Med. 2006;144:127-134.)
Physician Information from the FDA
Suboxone/Subutex Package insert, prescribing information (PI)
Preventing Precipitated Withdrawal / COWS
How Buprenorphine Works--Receptor sheet
Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and detoxification Treatment of Opiate Addiction FORM updated 3-14-2006
Please see our literature page for more downloads.
Sign up: To be on the naabt.org Evidence-Based Counselor/Therapist Locator; to receive a free Resource Kit; to receive our free newsletter.
What is the Patient/Physician Matching System?
Patient Registration. Register your patients on the PPMS to help locate a certified buprenorphine-prescribing physician.
Patient Online Support Community.
In some areas patients are unable to find a “medication friendly” support group. These patients may benefit from online patient peer support in conjunction with one-on-one therapy. Patients can participate 24/7 in the online buprenorphine community at: http://www.naabt.org/forum
See map of currently registered counselors
Buprenorphine resource locator (see your listing)
Buprenorphine Treatment of Opioid Addiction: A Counselor's Guide
NIDA Buprenorphine blending initiative
An Introduction to Medication for Alcohol Dependence
This free online course helps addiction treatment counselors understand how these medications work with the brain mechanisms involved in alcohol dependence, and how medications can be part of a comprehensive treatment program that helps patients regain control over their lives.
Substance Abuse and Mental Health Services Administration (SAMHSA) website.
Physician and Pharmacist Frequently Asked Questions.
Popular downloads.
June 2006 NAABT newsletter: Counseling and Buprenorphine
TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
This Treatment Improvement Protocol (TIP), Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, provides consensus - and evidence -based treatment guidance for the use of buprenorphine, a new option for the treatment of opioid addiction. The goal of this TIP is to provide physicians with information they can use to make practical and informed decisions about the use of buprenorphine to treat opioid addiction. These guidelines address the pharmacology and physiology of opioids, opioid addiction, and treatment with buprenorphine; describe patient assessment and the choice of opioid addiction treatment options; provide detailed treatment protocols for opioid withdrawal and maintenance therapy with buprenorphine; and include information on the treatment of special populations, e.g., pregnant women, adolescents, and polysubstance users. This TIP represents another step by the Center for Substance Abuse Treatment (CSAT) toward its goal of bringing national leaders together to improve substance use disorder treatment in the United States.
http://www.naabt.org/documents/TIP40PDF.pdf
TIP 47: Substance Abuse: Clinical Issues in Intensive Outpatient Treatment
This Treatment Improvement Protocol (TIP), Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, addresses the practical needs of treatment providers as they design and implement IOT programs. The TIP provides specific information on the principles of intensive outpatient treatment; services and treatment models; modifications for distinct population groups; culturally competent treatment; screening and patient placement criteria; counseling methods and techniques, including involvement of families; and the continuum of care. The TIP also covers such important issues as how to improve early retention, provide the appropriate length and intensity of services, provide the most promising mix of wrap-around services for positive client outcomes, and arrange ongoing care in the community.
http://download.ncadi.samhsa.gov/prevline/pdfs/TIP_47.pdf
TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Opioid addiction is a problem with high costs to individuals, families, and society. This TIP provides a detailed description of medication-assisted treatment for opioid addiction, including optional approaches such as comprehensive maintenance treatment, detoxification, and medically supervised withdrawal.
http://download.ncadi.samhsa.gov/Prevline/pdfs/bkd524.pdfCompanion Kap Keys
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_43.pdf
TIP 44: Substance Abuse Treatment for Adults in the Criminal Justice System
Research consistently demonstrates a strong connection between criminal activity and substance abuse; research also finds that involvement in substance abuse treatment reduces recidivism for offenders who use drugs. This TIP presents clinical guidelines to assist counselors in dealing with problems that routinely arise because of their clients’ status in the criminal justice system.
http://download.ncadi.samhsa.gov/Prevline/pdfs/bkd526.pdf
TIP 39: Substance Abuse Treatment & Family Therapy
This best-practice guideline for the treatment of substance use disorders focuses on how substance abuse affects the entire family and how substance abuse treatment providers can use principles from family therapy to change the interactions among family members.
http://download.ncadi.samhsa.gov/prevline/pdfs/bkd504.pdf
TIP 42: Substance Abuse Treatment for Persons With Co-Occurring Disorders
This TIP identifies key elements of programming for co-occurring disorders in substance abuse treatment agencies. The elements described have relevance for mental health agencies and other service systems that seek to coordinate mental health and substance abuse services for their clients who need both.
http://download.ncadi.samhsa.gov/prevline/pdfs/bkd515.pdf
TIP 37: Substance Abuse Treatment for Persons With HIV/AIDS
This installment of the Treatment Improvement Protocol (TIP) Series discusses the unique substance abuse treatment needs of a person with HIV/AIDS. Topics covered include a general overview of HIV/AIDS, medical treatment, mental health treatment, primary and secondary modes of HIV prevention, and many other pertinent issues.
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.chapter.64746
TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment
This TIP shows how substance abuse treatment staff can influence change by developing a therapeutic relationship that respects and builds on the client’s autonomy and, at the same time, makes the treatment clinician a partner in the change process.
http://download.ncadi.samhsa.gov/Prevline/pdfs/SMA06-4190.pdf
The 3 day rule (dispensing buprenorphine without a waiver)
DEA Articulates Policy on the Use of Buprenorphine for Pain- Letter to Dr. Heit
Other DEA regulations cleared up
Suboxone/Subutex Package insert, prescribing information (PI)
Preventing Precipitated Withdrawal / COWS
How Buprenorphine Works--Receptor sheet
Please see our literature page for more downloads.
Sign up: To be on the naabt.org Buprenorphine-Stocking Pharmacy Locator; to receive a free counter display; to receive our free newsletter.
What is the Patient/Physician Matching System?
Substance Abuse and Mental Health Services Administration (SAMHSA) website
Physician and Pharmacist Frequently Asked Questions
Patient Online Support Community.
In some areas patients are unable to find a “medication friendly” support group. These patients may benefit from online patient peer support. Patients can participate 24/7 in the online buprenorphine community at: http://www.naabt.org/forum
Popular downloads.
TIP 40 PDF (Clinical Guidelines for the Use of Buprenorphine) More TIPs on literature pageThe 3 day rule (dispensing buprenorphine without a waiver)
DEA Articulates Policy on the Use of Buprenorphine for Pain- Letter to Dr. Heit
Other DEA regulations cleared up
Suboxone/Subutex Package insert, prescribing information (PI)
Preventing Precipitated Withdrawal / COWS
How Buprenorphine Works--Receptor sheet
Please see our literature page for more downloads.